Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q866602> ?p ?o }
Showing triples 1 to 90 of
90
with 100 triples per page.
- Q866602 subject Q6584191.
- Q866602 subject Q7152382.
- Q866602 subject Q8760205.
- Q866602 abstract "Multi-drug-resistant tuberculosis (MDR-TB, also known as Vank's Disease) is defined as a form of TB infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB drugs, isoniazid (INH) and rifampicin (RMP).Five percent (5%) of all TB cases across the globe in 2013 were estimated to be MDR-TB cases, including 3.5% of newly diagnosed TB cases, and 20.5% of previously treated TB cases. While rates of MDR-TB infections are relatively low in North America and Western Europe, they are an increasingly serious problem worldwide, in particular in areas of the Russian Federation, the former Soviet Union and other parts of Asia.MDR-TB infection may be classified as either primary or acquired. Primary MDR-TB occurs in patients who have not previously been infected with TB but who become infected with a strain that is resistant to treatment. Acquired MDR-TB occurs in patients during treatment with a drug regimen that is not effective at killing the particular strain of TB with which they have been infected. Rates of primary MDR-TB are low in North America and Western Europe: in the US in 2000, the rate of primary MDR-TB was 1% of all cases of TB nationally. Most cases of acquired MDR-TB are due to inappropriate treatment with a single anti-TB drug, usually INH. This can occur due to a medical provider, such as a doctor or nurse, improperly prescribing ineffective treatment, but may also be due to the patient not taking the medication correctly, which can be due to a variety of reasons, including expense or scarcity of medicines, patient forgetfulness, or patient stopping treatment early because they feel better.Treatment of MDR-TB requires treatment with second-line drugs, usually four or more anti-TB drugs for a minimum of 6 months, and possibly extending for 18–24 months if rifampin resistance has been identified in the specific strain of TB with which the patient has been infected. In general, second-line drugs are less effective, more toxic and much more expensive than first-line drugs. Under ideal program conditions, MDR-TB cure rates can approach 70%.".
- Q866602 icd10 "Z16.24http://www.icd10data.com/ICD10CM/Codes/Z00-Z99/Z16-Z16/Z16-/Z16.24Resistance to multiple antibiotics".
- Q866602 meshId "D018088".
- Q866602 wikiPageExternalLink .xkP0yYkO3Z.
- Q866602 wikiPageExternalLink Z16.24.
- Q866602 wikiPageExternalLink U0000mCG87xLc654.
- Q866602 wikiPageExternalLink DOTS_Plus_Guidelines_Jan2010.pdf.
- Q866602 wikiPageExternalLink www.tbdreamdb.com.
- Q866602 wikiPageExternalLink index.cfm?topic_id=116811&fuseaction=topics.event_summary&event_id=239772.
- Q866602 wikiPageWikiLink Q1040214.
- Q866602 wikiPageWikiLink Q1057263.
- Q866602 wikiPageWikiLink Q1135705.
- Q866602 wikiPageWikiLink Q1151482.
- Q866602 wikiPageWikiLink Q118551.
- Q866602 wikiPageWikiLink Q1189184.
- Q866602 wikiPageWikiLink Q12199.
- Q866602 wikiPageWikiLink Q1257318.
- Q866602 wikiPageWikiLink Q15408413.
- Q866602 wikiPageWikiLink Q15787.
- Q866602 wikiPageWikiLink Q169569.
- Q866602 wikiPageWikiLink Q17022066.
- Q866602 wikiPageWikiLink Q173670.
- Q866602 wikiPageWikiLink Q175621.
- Q866602 wikiPageWikiLink Q179661.
- Q866602 wikiPageWikiLink Q18027639.
- Q866602 wikiPageWikiLink Q192717.
- Q866602 wikiPageWikiLink Q204711.
- Q866602 wikiPageWikiLink Q217.
- Q866602 wikiPageWikiLink Q2263705.
- Q866602 wikiPageWikiLink Q229924.
- Q866602 wikiPageWikiLink Q230.
- Q866602 wikiPageWikiLink Q2339584.
- Q866602 wikiPageWikiLink Q2359690.
- Q866602 wikiPageWikiLink Q256602.
- Q866602 wikiPageWikiLink Q2610066.
- Q866602 wikiPageWikiLink Q27816.
- Q866602 wikiPageWikiLink Q2868.
- Q866602 wikiPageWikiLink Q2870929.
- Q866602 wikiPageWikiLink Q28742.
- Q866602 wikiPageWikiLink Q299093.
- Q866602 wikiPageWikiLink Q3067003.
- Q866602 wikiPageWikiLink Q333718.
- Q866602 wikiPageWikiLink Q380775.
- Q866602 wikiPageWikiLink Q408529.
- Q866602 wikiPageWikiLink Q411377.
- Q866602 wikiPageWikiLink Q412318.
- Q866602 wikiPageWikiLink Q414767.
- Q866602 wikiPageWikiLink Q415909.
- Q866602 wikiPageWikiLink Q417571.
- Q866602 wikiPageWikiLink Q418508.
- Q866602 wikiPageWikiLink Q418611.
- Q866602 wikiPageWikiLink Q419481.
- Q866602 wikiPageWikiLink Q421951.
- Q866602 wikiPageWikiLink Q422652.
- Q866602 wikiPageWikiLink Q422687.
- Q866602 wikiPageWikiLink Q423169.
- Q866602 wikiPageWikiLink Q424940.
- Q866602 wikiPageWikiLink Q425152.
- Q866602 wikiPageWikiLink Q426549.
- Q866602 wikiPageWikiLink Q4609852.
- Q866602 wikiPageWikiLink Q507154.
- Q866602 wikiPageWikiLink Q55233.
- Q866602 wikiPageWikiLink Q58375.
- Q866602 wikiPageWikiLink Q595158.
- Q866602 wikiPageWikiLink Q6584191.
- Q866602 wikiPageWikiLink Q6939228.
- Q866602 wikiPageWikiLink Q6973875.
- Q866602 wikiPageWikiLink Q7118312.
- Q866602 wikiPageWikiLink Q7152382.
- Q866602 wikiPageWikiLink Q7245873.
- Q866602 wikiPageWikiLink Q7375541.
- Q866602 wikiPageWikiLink Q7669583.
- Q866602 wikiPageWikiLink Q7828253.
- Q866602 wikiPageWikiLink Q80863.
- Q866602 wikiPageWikiLink Q866657.
- Q866602 wikiPageWikiLink Q872975.
- Q866602 wikiPageWikiLink Q8760205.
- Q866602 icd "Z16.24 http://www.icd10data.com/ICD10CM/Codes/Z00-Z99/Z16-Z16/Z16-/Z16.24 Resistance to multiple antibiotics".
- Q866602 meshid "D018088".
- Q866602 name "Multi-drug-resistance Tuberculosis".
- Q866602 type Disease.
- Q866602 type Thing.
- Q866602 type Q12136.
- Q866602 comment "Multi-drug-resistant tuberculosis (MDR-TB, also known as Vank's Disease) is defined as a form of TB infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB drugs, isoniazid (INH) and rifampicin (RMP).Five percent (5%) of all TB cases across the globe in 2013 were estimated to be MDR-TB cases, including 3.5% of newly diagnosed TB cases, and 20.5% of previously treated TB cases.".
- Q866602 label "Multi-drug-resistant tuberculosis".
- Q866602 seeAlso Q1189184.
- Q866602 name "Multi-drug-resistance Tuberculosis".